Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Groww, Lenskart, 9 other stocks among Motilal’s non-Nifty ideas. Check full list
Motilal Oswal has revealed its top non-Nifty stock picks. The brokerage anticipates robust earnings growth for these companies. Key names include ICICI Prudential AMC, TVS Motor, and Dixon Technologies. Delhivery shows the highest projected earnings expansion. Investors can explore these opportunities for potential gains.
Ipca Labs In Focus As Motilal Oswal Remains Bullish After Inline Q4 Results — Check Target Price, Upside
Ipca Labs delivered a steady performance in the March quarter, with Motilal Oswal maintaining its bullish stance, citing strong growth visibility in domestic formulations and export markets.
Asian Paints shares rally 4% after Q4 results. Here’s what Nomura and Motilal Oswal are saying
Asian Paints shares rose sharply after the company reported a 69% year-on-year jump in Q4FY26 profit and stronger margins. While Nomura reiterated its Buy call with a Rs 3,600 target price, Motilal Oswal maintained a Neutral stance, citing demand uncertainties despite raising earnings estimates and growth expectations.
Ashok Leyland Shares In Focus As Motilal Oswal Stays Bullish Despite Near-Term Headwinds — Check Target Price, Upside And More
Ashok Leyland delivered an in-line operational performance for Q4, with Motilal Oswal maintaining a bullish stance on the stock's long-term earnings outlook despite near-term demand uncertainties.
Premier Energies shares in focus as promoters sell stake worth Rs 2,289 crore. Check top buyers
Promoter family members of Premier Energies sold shares worth around Rs 2,289 crore through a block deal, while institutional investors, including Quant Mutual Fund and Nomura, picked up stakes. The development comes amid strong investor interest in renewable energy and domestic solar manufacturing, supported by robust earnings growth and aggressive capacity expansion plans.
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.
Zydus LifeSciences Shares in Focus: Motilal Oswal Maintains Neutral Rating on Limited Upside — Check Revised Target Price
The current valuation provides limited upside and hence, Motilal Oswal has maintained Neutral rating on Zydus Lifesciences.
After Nomura, Motilal Oswal also sees gold duty hike manageable for Titan
Motilal Oswal believes Titan is well-equipped to manage the situation through superior gold sourcing capabilities and a strong balance sheet.
Canara HSBC Life In Focus as Motilal Oswal Bets on Multi-Year Compounding Story — Check Target Price, Upside
The differentiated dual-bank partnership with mass scale from Canara Bank and premium affluence from HSBC creates a distribution backbone that only a few private life insurers possess.
Nifty Bank falls 500 points as PNB, Canara Bank, SBI, other stocks decline up to 3%. What lies ahead?
Indian bank stocks tumbled, dragging the Nifty Bank index down as a weakening rupee and rising global bond yields soured market sentiment. Several major banks saw significant declines, with analysts pointing to key technical levels. The rupee hit an all-time low against the dollar, exacerbating concerns for the financial sector.
SAIL Shares in Focus After Strong Q4; Motilal Oswal Stays Bullish With Higher Target Price — Check New Upside
SAIl remained in focus after Motilal Oswal reiterated its Buy rating on the stock and revised the target price upward.
Top Gainers & Losers on May 15: HUDCO, Muthoot Finance, Voltas, IOCL, Vedanta, HAL, Aditya Infotech among top losers
On May 15, Indian markets declined, with Nifty down 0.18% and Sensex down 0.25%. Selling in financial and metal stocks offset IT sector gains. The rupee hit a record low of 96.5 against the dollar, influenced by foreign investor withdrawals and rising crude oil prices.